Assessing and Improving Value in Cancer Care Workshop Summary (2009) / Chapter Skim
Currently Skimming:
Appendix A: Workshop Agenda
Appendix A: Workshop Agenda
Pages 125-128
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 125... ...
Ramsey, Fred Hutchinson Cancer Research Center 8:20 P hysician–Patient Communication and Its Influence on Value Moderator: Allen S Lichter, American Society of Clinical Oncology 8:25 Inside the Physician–Patient Discussion in Cancer Care Speaker: Anthony Back, University of Washington 8:55 Invited Comments from Diane Blum, CancerCare 9:00 C an We Communicate Effectively with Cancer Patients About the Benefits and Risks of Cancer Treatments?
|
From page 126... ...
Cohen, Agency for Healthcare Research and Quality 10:55 FDA Perspectives on Evidence for Regulatory Approval in Cancer Speaker: Janet Woodcock, Food and Drug Administration 11:25 What Constitutes Reasonable Evidence of Efficacy and Effectiveness? Speaker: Daniel J
|
From page 127... ...
Moses, Vanderbilt-Ingram Cancer Center 8:05 Ethical Issues When Considering Insurance Coverage Based on Value in the Treatment of Cancer Speaker: Dan W Brock, Harvard Medical School
|
From page 128... ...
Toward a Shared Understanding of Value: Can We Agree, and Does Perspective Matter? Moderator: Peter Bach, Memorial Sloan-Kettering Cancer Center Panel: All Moderators 1:30 Meeting Adjourned
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.